Results 211 to 220 of about 816,058 (304)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study. [PDF]

Hemasphere
Polverelli N, Chiappella A, Carniti C, Zinzani P, Musso M, Tisi MC, Ciceri F, Cutini I, Santoro A, Chiusolo P, Barbui AM, Farina M, Donzelli L, Brunello L, Martino M, Krampera M, Castellino A, Grillo G, Botto B, Olivieri J, Clerico M, Musto P, Olivieri A, Bianchessi A, Defrancesco I, Losi G, Zerbi C, Martini G, Roncoroni E, Gotti M, Benevento MG, Taurino A, Fedina A, Corradini P, Arcaini L.   +34 more
europepmc   +1 more source

A Hoveyda–Grubbs‐Type Olefin Metathesis Catalyst Bearing a Fluorinated Unsymmetrical NHC Ligand

European Journal of Inorganic Chemistry, EarlyView.
A fluorinated unsymmetrical NHC ruthenium complex was synthesised and employed as a catalyst for olefin metathesis reactions. The modification of the steric and electronic properties of the NHC ligand through the introduction of fluorine substituents results in improved activity but lower selectivity compared to the analogous non‐fluorinated NHC ...
Rubina Troiano, Concetta Liguori, Chiara Costabile, Fabia Grisi   +3 more
wiley   +1 more source

Safracin B as a Synthetic Linchpin: From Natural Product to Drug Intermediate and Beyond

European Journal of Organic Chemistry, EarlyView.
Safracin B is employed as a key precursor for the streamlined preparation of cyanosafracin B and safracin A. Careful tuning of the reaction parameters affords these derivatives in high efficiency, and full nuclear magnetic resonance signal assignments are established for the complex safracin frameworks.
Paolo Orlando, Simone Borsoi, Valerio Fasano, Andrea Citarella, Pietro Allegrini, Daniele Passarella   +5 more
wiley   +1 more source

Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. <i>Cancers</i> 2026, <i>18</i>, 1037. [PDF]

Cancers (Basel)
Prisciandaro E, Bertolaccini L, Fieuws S, Cara A, Spaggiari L, Huang L, Petersen RH, Lucchi M, Mastromarino MG, Barbarossa A, De Leyn P, Roffinella M, Ruffini E, Donlagic A, Gonzalez M, Fuentes-Gago MG, Forcada-Barreda C, Congedo MT, Margaritora S, Belaroussi Y, Thumerel M, Tricard J, Felix P, Lebeda N, Opitz I, De Palma A, Marulli G, Braggio C, Thomas PA, Mbadinga F, Baste JM, Sayan B, Yildizeli B, Dekervel J, Van Raemdonck DE, Weder W, Ceulemans LJ.   +36 more
europepmc   +1 more source

Colchicine in patients with chronic inflammatory cardiomyopathy: rationale and design of the CMP-MYTHiC. [PDF]

ESC Heart Fail
Ammirati E, Cartella I, Ciabatti M, Colombo G, Masetti M, Pieroni M, Gallone G, Peretto G, Potena L, Scacciavillani R, Raineri C, Caputo A, Pedrotti P, Sormani P, Conti N, Merlo M, Imazio M, Pani A, Ciliberti ML, Gentile P, Pontone G, Villatore A, Pezzullo E, Palazzini M, Casella M, Valsecchi MG, Burzotta F, Carmina V, Garascia A, Scarale AF, Bernasconi DP, Loffredo FS, Narducci ML.   +32 more
europepmc   +1 more source

By‐product of heparin extraction as a sustainable alternative to enhance the use of nitrogen in agriculture

Environmental Progress &Sustainable Energy, EarlyView.
Abstract This study evaluates the potential of a new organic fertilizer derived from porcine intestinal mucosa (designated BHE), a by‐product of the heparin extraction process, as a sustainable nitrogen (N) source for agriculture. The work was conducted in two stages: (i) chemical and spectroscopic characterization of BHE compared with poultry litter ...
Aline Zanquetti, Felipe Augusto Bueno Rossi, Jonatas Thiago Piva, Larissa Macedo dos Santos‐Tonial   +3 more
wiley   +1 more source

Absence of SARS-CoV-2 in Placental Tissue After Maternal COVID-19.

JAMA Netw Open
Farhadian SF, Orlinick B, Milano KM, Mekael D, Kliman HJ.   +4 more
europepmc   +1 more source

Secondary Intention Healing of Extensive Nasal Defects: A Multimodal Approach to Optimize Esthetic Outcomes. [PDF]

Case Rep Dermatol Med
Ribas DBR, Garretto YTM, Ramos DG, Milano GI, de Oliveira GV.   +4 more
europepmc   +1 more source